Blackstone Pours $125M Into NantWorks Biopharmaceutical Arm
New York private equity giant Blackstone Group LP invested $125 million in a division of Los Angeles-based health care company NantWorks LLC to help advance the development of biologically derived pharmaceuticals,...To view the full article, register now.
Already a subscriber? Click here to view full article